5th Annual Chemical Biology & Molecular Medicine Symposium
- 👤 Speaker: Department of Chemistry, University of Cambridge
- 📅 Date & Time: Monday 10 October 2011, 08:45 - 18:00
- 📍 Venue: CRUK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE
Abstract
CANCER THEME
The Cambridge PhD Training Programme in Chemical Biology & Molecular Medicine will be holding its annual symposium on the Addenbrooke’s site at the Cancer Research UK Cambridge Research Institute on Monday 10th October.
Speakers will include:
TOM HEIGHTMAN (Director of Medicinal Chemistry, Astex) our annual keynote lecture – Epigenetic Drug Discovery
KJ PATEL (MRC Laboratory of Molecular Biology) – Protecting Against the Genotoxic Consequences of Naturally Produced Reactive Aldehydes
STEVE JACKSON (Wellcome Trust/CRUK Gurdon Institute) – Cellular Responses to DNA Damage: Drug Discovery and Drug Evaluation
Plus research updates from the programme’s PhD students:
Developing a Novel Approach Towards “Synthetic Lectins” with the View of Imaging Cancer Cell Glycoproteins (Yelena Wainman)
Genetic Instability and Cancer: Inhibiting Aurora Kinase A and TPX2 Interaction (Matej Janecek)
Designing Novel Bioorthogonal Reactions for the Site-Selective Glycosylation of Proteins (Lily Chan)
DNA Modifications and Epigenetic Processes in Cancer Progression and Metastasis (Martin Bachman)
Fragment Based Design of Inhibitors of the TPX2 -Importin-α Interaction (Rhian Holvey)
Biophysical Evaluation of the Rad51-BRCA2 Protein-Protein Interaction and the Design and Synthesis of Inhibitors (Luca Laraia)
Synthesis and Biological Evaluation of Allosteric Inhibitors of the Motor Protein, HSET (Ciorsdaidh Watts)
New Approaches in Epigenetic Therapy: Non-coding RNA as a Target for Polycomb Inhibition (Liang Wu)
Unravelling Uncinatone: Piecing Together the Clues Towards a Potential Topoisomerase II Inhibitor (Andrew Lewis)
Allosteric Polo-like Kinase 1 Inhibitors: A Fragment-Based Approach (Christopher Stubbs)
Development of Novel Small Molecule Inhibitors of XIAP -Caspase 9 Interactions (Danny Allwood)
Cyclopamine: Inspiration for Novel Inhibitors of the Hedgehog Signalling Pathway (Elliott Bayle)
Ruthenium-based Enzyme Inhibitors: Pioneering a New Generation of Metallodrugs (Simon Page)
There will also be a POSTER SESSION . There is still space to accommodate a few more posters. If you are interested in presenting your relevant research please contact me asap. The symposium is free to attend – but please email rmm32@cam.ac.uk to register ASAP .
See programme website for further details: http://www-medchem.ch.cam.ac.uk/
Series This talk is part of the Cambridge PhD Training Programme in Chemical Biology & Molecular Medicine series.
Included in Lists
- Cambridge PhD Training Programme in Chemical Biology & Molecular Medicine
- CRUK Cambridge Research Institute, Li Ka Shing Centre, Robinson Way, Cambridge, CB2 0RE
Note: Ex-directory lists are not shown.
![[Talks.cam]](/static/images/talkslogosmall.gif)


Monday 10 October 2011, 08:45-18:00